{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:35:27Z","timestamp":1791304527676,"version":"4.3.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81202003"],"award-info":[{"award-number":["81202003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.tranon.2026.102664","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T19:23:38Z","timestamp":1768245818000},"page":"102664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Spatial and single-cell multi-omics reveal pro-angiogenic THY1\u207a fibroblast subtypes predicting prognosis in prostate cancer"],"prefix":"10.1016","volume":"65","author":[{"given":"Yongqiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.tranon.2026.102664_bib0001","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMa"},{"key":"10.1016\/j.tranon.2026.102664_bib0002","article-title":"Age-sex-specific burden of urological cancers attributable to risk factors in China and its provinces, 1990-2021, and forecasts with scenarios simulation: a systematic analysis for the global burden of disease study 2021","volume":"56","author":"Xue","year":"2025","journal-title":"Lancet Reg. Health West Pac."},{"issue":"3","key":"10.1016\/j.tranon.2026.102664_bib0003","article-title":"Assessment of immune cell populations in the peripheral blood of patients with metastatic prostate cancer","volume":"17","author":"Patel","year":"2025","journal-title":"Cureus."},{"issue":"3","key":"10.1016\/j.tranon.2026.102664_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/ph17030351","article-title":"The current therapeutic landscape for metastatic prostate cancer","volume":"17","author":"Bernal","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","article-title":"Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance","volume":"6","author":"Ge","year":"2022","journal-title":"NPJ. Precis. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102664_bib0006","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/1061186X.2024.2418344","article-title":"Interactions and communications in the prostate tumour microenvironment: evolving towards effective cancer therapy","volume":"33","author":"Dai","year":"2025","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.tranon.2026.102664_bib0007","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41391-024-00825-z","article-title":"Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer","volume":"28","author":"Fang","year":"2025","journal-title":"Prostate Cancer Prostatic. Dis."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010067","article-title":"Cancer-associated fibroblast heterogeneity, activation and function: implications for prostate cancer","volume":"13","author":"Owen","year":"2022","journal-title":"Biomolecules."},{"key":"10.1016\/j.tranon.2026.102664_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.655152","article-title":"Cancer-Associated Fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer","volume":"9","author":"Geng","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102664_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MOU.0000000000000987","article-title":"Tumour microenvironment and focal therapy for prostate cancer","volume":"32","author":"Borges","year":"2022","journal-title":"Curr. Opin. Urol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0011","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.12978","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.tranon.2026.102664_bib0012","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41416-019-0509-3","article-title":"Cancer-associated fibroblasts-heroes or villains?","volume":"121","author":"Gieniec","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2026.102664_bib0013","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2026.102664_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102255","article-title":"Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: implications for prognosis and immunotherapy","volume":"52","author":"Ding","year":"2025","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0015","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","article-title":"Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing","volume":"9","author":"Bartoschek","year":"2018","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.tranon.2026.102664_bib0016","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104063","article-title":"Stromal cell diversity associated with immune evasion in human triple-negative breast cancer","volume":"39","author":"Wu","year":"2020","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.tranon.2026.102664_bib0017","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.tranon.2026.102664_bib0018","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.3818","article-title":"Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors","volume":"49","author":"Li","year":"2017","journal-title":"Nat. Genet."},{"issue":"13","key":"10.1016\/j.tranon.2026.102664_bib0019","doi-asserted-by":"crossref","first-page":"11379","DOI":"10.1007\/s00432-023-05011-7","article-title":"Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing","volume":"149","author":"Li","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","article-title":"Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression","volume":"23","author":"Chen","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"18","key":"10.1016\/j.tranon.2026.102664_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305724","article-title":"Integration analysis of single-cell multi-omics reveals prostate cancer heterogeneity","volume":"11","author":"Bian","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.tranon.2026.102664_bib0022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2021.10.028","article-title":"Fibroblast heterogeneity in prostate carcinogenesis","volume":"525","author":"ChallaSivaKanaka","year":"2022","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.tranon.2026.102664_bib0023","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/modpathol.2010.122","article-title":"CD90\/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker","volume":"23","author":"True","year":"2010","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.tranon.2026.102664_bib0024","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/pros.20946","article-title":"Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts","volume":"69","author":"Zhao","year":"2009","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.tranon.2026.102664_bib0025","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/neuonc\/noac063","article-title":"USF1\/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion","volume":"24","author":"Zhou","year":"2022","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102664_bib0026","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/CBM-160590","article-title":"CD90 a potential cancer stem cell marker and a therapeutic target","volume":"16","author":"Shaikh","year":"2016","journal-title":"Cancer Biomark."},{"issue":"9","key":"10.1016\/j.tranon.2026.102664_bib0027","doi-asserted-by":"crossref","first-page":"11611","DOI":"10.1007\/s13277-016-5112-0","article-title":"Multiple roles of CD90 in cancer","volume":"37","author":"Kumar","year":"2016","journal-title":"Tumour. Biol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102664_bib0028","first-page":"122","article-title":"Thy-1 glycoprotein: structure, distribution, and ontogeny","volume":"54","author":"Crawford","year":"1986","journal-title":"Lab. Invest."},{"key":"10.1016\/j.tranon.2026.102664_bib0029","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.isci.2019.02.032","article-title":"Functional heterogeneity of mouse prostate stromal cells revealed by single-cell RNA-seq","volume":"13","author":"Kwon","year":"2019","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12307-010-0061-4","article-title":"Differential inductive signaling of cd90 prostate cancer-associated fibroblasts compared to normal tissue stromal mesenchyme cells","volume":"4","author":"Pascal","year":"2011","journal-title":"Cancer Microenviron."},{"issue":"3","key":"10.1016\/j.tranon.2026.102664_bib0031","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cjp2.205","article-title":"A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer","volume":"7","author":"Hesterberg","year":"2021","journal-title":"J. Pathol. Clin. Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0032","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/annonc\/mdx637","article-title":"Validation of a metastatic assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy","volume":"29","author":"Jain","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2026.102664_bib0033","article-title":"Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making","volume":"2017","author":"Abida","year":"2017","journal-title":"JCo Precis. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2026.102664_bib0034","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-13-2699","article-title":"Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence","volume":"74","author":"Long","year":"2014","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.tranon.2026.102664_bib0035","first-page":"13","article-title":"A systems approach to interrogate gene expression patterns in african american men presenting with clinically localized prostate cancer","author":"Hardiman","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0036","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12885-020-06817-1","article-title":"Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential","volume":"20","author":"Miller","year":"2020","journal-title":"BMC. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0037","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses","volume":"14","author":"Hirz","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0038","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41467-021-27322-4","article-title":"Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states","volume":"13","author":"Song","year":"2022","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.tranon.2026.102664_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.tranon.2026.102664_bib0040","article-title":"DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0041","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1002\/ctm2.1552","article-title":"Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: implications for prognosis and therapy prediction","volume":"14","author":"Ge","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"7735","key":"10.1016\/j.tranon.2026.102664_bib0042","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.tranon.2026.102664_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108955","article-title":"Spatial gene expression analysis reveals characteristic gene expression patterns of de novo neuroendocrine prostate cancer coexisting with androgen receptor pathway prostate cancer","volume":"24","author":"Watanabe","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0044","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.1038\/s41467-024-54364-1","article-title":"Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer","volume":"15","author":"Kiviaho","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102664_bib0045","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.tranon.2026.102664_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for Cox's proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J. Stat. Softw."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0047","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12935-021-02252-9","article-title":"Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer","volume":"21","author":"Zheng","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tranon.2026.102664_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1158863","article-title":"Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics","volume":"13","author":"Gu","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0049","article-title":"Development and validation of a cancer-associated fibroblast gene signature-based model for predicting immunotherapy response in colon cancer","volume":"15","author":"Zou","year":"2025","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.tranon.2026.102664_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104876","article-title":"Identification of cancer associated fibroblasts related genes signature to facilitate improved prediction of prognosis and responses to therapy in patients with pancreatic cancer","volume":"26","author":"Zhou","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.tranon.2026.102664_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28673","article-title":"The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer","volume":"10","author":"Cai","year":"2024","journal-title":"Heliyon."},{"key":"10.1016\/j.tranon.2026.102664_bib0052","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fphar.2019.00307","article-title":"Activation of CXCL6\/CXCR1\/2 axis promotes the growth and metastasis of osteosarcoma cells in vitro and in vivo","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102664_bib0053","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1139\/bcb-2015-0136","article-title":"CXCL6 promotes human hepatocyte proliferation through the CXCR1-NF\u03baB pathway and inhibits collagen I secretion by hepatic stellate cells","volume":"94","author":"Li","year":"2016","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.tranon.2026.102664_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.579874","article-title":"CXC chemokine\/receptor axis profile and metastasis in prostate cancer","volume":"7","author":"Nagaya","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tranon.2026.102664_bib0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2022.01.015","article-title":"Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer","volume":"530","author":"Kang","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0056","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tranon.2026.102664_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.719922","article-title":"Regulation of extracellular matrix production in activated fibroblasts: roles of amino acid metabolism in collagen synthesis","volume":"11","author":"Kay","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.tranon.2026.102664_bib0058","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/mc.23233","article-title":"Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling","volume":"59","author":"Suh","year":"2020","journal-title":"Mol. Carcinog."},{"issue":"8","key":"10.1016\/j.tranon.2026.102664_bib0059","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.7150\/thno.53412","article-title":"Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics."},{"issue":"18","key":"10.1016\/j.tranon.2026.102664_bib0060","first-page":"13","article-title":"The role of cancer-associated fibroblasts in cancer invasion and metastasis","author":"Asif","year":"2021","journal-title":"Cancers. (Basel)"},{"issue":"9","key":"10.1016\/j.tranon.2026.102664_bib0061","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.tranon.2026.102664_bib0062","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","article-title":"Identification of fibroblast heterogeneity in the tumor microenvironment","volume":"5","author":"Sugimoto","year":"2006","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0063","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12951-025-03217-0","article-title":"Regulation of cancer-associated fibroblasts for enhanced cancer immunotherapy using advanced functional nanomedicines: an updated review","volume":"23","author":"Liao","year":"2025","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.tranon.2026.102664_bib0064","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3389\/fcell.2020.00747","article-title":"Endothelial-to-mesenchymal transition in cancer","volume":"8","author":"Clere","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102664_bib0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2026.102664_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.698275","article-title":"Matrix stiffness induces pericyte-fibroblast transition through YAP activation","volume":"12","author":"Feng","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102664_bib0067","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3892\/ijmm.2013.1532","article-title":"H. pylori infection-induced MSC differentiation into CAFs promotes epithelial-mesenchymal transition in gastric epithelial cells","volume":"32","author":"Zhang","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"12","key":"10.1016\/j.tranon.2026.102664_bib0068","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.102664_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10255842.2025.2495299","article-title":"Identification of cancer-associated fibroblast characteristics for predicting outcome and response to immunotherapy in renal cell carcinoma","author":"Zhou","year":"2025","journal-title":"Comput. Methods Biomech. Biomed. Engin."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0070","doi-asserted-by":"crossref","first-page":"C252","DOI":"10.1152\/ajpcell.00234.2023","article-title":"Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization","volume":"326","author":"Zhang","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102664_bib0071","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the gleason score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102664_bib0072","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","article-title":"Prognostic Gleason grade grouping: data based on the modified Gleason scoring system","volume":"111","author":"Pierorazio","year":"2013","journal-title":"BJu Int."},{"issue":"8","key":"10.1016\/j.tranon.2026.102664_bib0073","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.urolonc.2012.05.001","article-title":"Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy","volume":"31","author":"Miyake","year":"2013","journal-title":"Urol. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102664_bib0074","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0090-4295(00)00791-3","article-title":"Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival","volume":"56","author":"Sakr","year":"2000","journal-title":"Urology."},{"issue":"1","key":"10.1016\/j.tranon.2026.102664_bib0075","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1038\/s41598-017-06922-5","article-title":"Thy-1(+) cancer-associated fibroblasts adversely impact lung cancer prognosis","volume":"7","author":"Schliekelman","year":"2017","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.tranon.2026.102664_bib0076","first-page":"25","article-title":"Immune microenvironment and the effect of vascular endothelial growth factor inhibition in hepatocellular carcinoma","author":"Oura","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102664_bib0077","article-title":"CAFs orchestrates tumor immune microenvironment-a new target in cancer therapy?","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332600001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332600001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:32:11Z","timestamp":1770712331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193652332600001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":77,"alternative-id":["S193652332600001X"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102664","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial and single-cell multi-omics reveal pro-angiogenic THY1\u207a fibroblast subtypes predicting prognosis in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102664"}}